Metabolic syndrome and the immunological affair with the blood-brain barrier

Frontiers in Immunology

Volumn 6, Issue JAN, 2015, Pages

  Mauro, Claudio ^a   De Rosa, Veronica ^b   Marelli Berg, Federica ^a   Solito, Egle ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b CNR   (Italy)

Author keywords

Blood brain barrier; Diet; Immune response; Leukocytes; Metabolism

Indexed keywords

GAMMA INTERFERON; GLUCOSE TRANSPORTER 1; INSULIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LEPTIN; MAMMALIAN TARGET OF RAPAMYCIN; T LYMPHOCYTE RECEPTOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ADAPTIVE IMMUNITY; BLOOD BRAIN BARRIER; BRAIN METABOLISM; CENTRAL NERVOUS SYSTEM FUNCTION; COGNITIVE DEFECT; HUMAN; IMMUNE RESPONSES; IMMUNOLOGY; INFLAMMATION; LEUKOCYTE MIGRATION; LIPID DIET; METABOLIC STRESS; METABOLIC SYNDROME X; PATHOLOGY; PROTEIN EXPRESSION; REVIEW; RISK FACTOR; T LYMPHOCYTE;

EID: 84926669246     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2014.00677     Document Type: Review

References (61)

1. Engelhardt B, Coisne C. Fluids and barriers of the CNS establish immune privilege by confining immune surveillance to a two-walled castle moat surrounding the CNS castle. Fluids Barriers CNS (2011) 8(1):4. doi:10.1186/2045-8118-8-4.
2. Abbott NJ, Ronnback L, Hansson E. Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci (2006) 7(1):41-53. doi:10.1038/nrn1824.
3. Neuwelt EA, Bauer B, Fahlke C, Fricker G, Iadecola C, Janigro D, et al. Engaging neuroscience to advance translational research in brain barrier biology. Nat Rev Neurosci (2011) 12(3):169-82. doi:10.1038/nrn2995.
4. Mehta D, Malik AB. Signaling mechanisms regulating endothelial permeability. Physiol Rev (2006) 86(1):279-367. doi:10.1152/physrev.00012.2005.
5. Abbott NJ, Patabendige AA, Dolman DE, Yusof SR, Begley DJ. Structure and function of the blood-brain barrier. Neurobiol Dis (2010) 37(1):13-25. doi:10.1016/j.nbd.2009.07.030.
6. Cristante E, McArthur S, Mauro C, Maggioli E, Romero IA, Wylezinska-Arridge M, et al. Identification of an essential endogenous regulator of blood-brain barrier integrity, and its pathological and therapeutic implications. Proc Natl Acad Sci U S A (2013) 110(3):832-41. doi:10.1073/pnas.1209362110.
7. Neuwelt E, Abbott NJ, Abrey L, Banks WA, Blakley B, Davis T, et al. Strategies to advance translational research into brain barriers. Lancet Neurol (2008) 7(1):84-96. doi:10.1016/S1474-4422(07)70326-5.
8. Romero IA, Radewicz K, Jubin E, Michel CC, Greenwood J, Couraud PO, et al. Changes in cytoskeletal and tight junctional proteins correlate with decreased permeability induced by dexamethasone in cultured rat brain endothelial cells. Neurosci Lett (2003) 344(2):112-6. doi:10.1016/S0304-3940(03)00348-3.
9. Nimmo AJ, Vink R. Recent patents in CNS drug discovery: the management of inflammation in the central nervous system. Recent Pat CNS Drug Discov (2009) 4(2):86-95. doi:10.2174/157488909788452997.
10. Ransohoff RM, Engelhardt B. The anatomical and cellular basis of immune surveillance in the central nervous system. Nat Rev Immunol (2012) 12(9):623-35. doi:10.1038/nri3265.
11. Miller DW. Immunobiology of the blood-brain barrier. J Neurovirol (1999) 5(6):570-8. doi:10.3109/13550289909021286.
12. Wilson EH, Weninger W, Hunter CA. Trafficking of immune cells in the central nervous system. J Clin Invest (2010) 120(5):1368-79. doi:10.1172/JCI41911.
13. Ousman SS, Kubes P. Immune surveillance in the central nervous system. Nat Neurosci (2012) 15(8):1096-101. doi:10.1038/nn.3161.
14. Lodygin D, Odoardi F, Schlager C, Korner H, Kitz A, Nosov M, et al. A combination of fluorescent NFAT and H2B sensors uncovers dynamics of T cell activation in real time during CNS autoimmunity. Nat Med (2013) 19(6):784-90. doi:10.1038/nm.3182.
15. Odoardi F, Sie C, Streyl K, Ulaganathan VK, Schlager C, Lodygin D, et al. T cells become licensed in the lung to enter the central nervous system. Nature (2012) 488(7413):675-9. doi:10.1038/nature11337.
16. Ifergan I, Kebir H, Alvarez JI, Marceau G, Bernard M, Bourbonniere L, et al. Central nervous system recruitment of effector memory CD8+ T lymphocytes during neuroinflammation is dependent on alpha4 integrin. Brain (2011) 134(Pt 12):3560-77. doi:10.1093/brain/awr268.
17. Reboldi A, Coisne C, Baumjohann D, Benvenuto F, Bottinelli D, Lira S, et al. C-C chemokine receptor 6-regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE. Nat Immunol (2009) 10(5):514-23. doi:10.1038/ni.1716.
18. Arima Y, Harada M, Kamimura D, Park JH, Kawano F, Yull FE, et al. Regional neural activation defines a gateway for autoreactive T cells to cross the blood-brain barrier. Cell (2012) 148(3):447-57. doi:10.1016/j.cell.2012.01.022.
19. Wolf AM, Colditz GA. Current estimates of the economic cost of obesity in the United States. Obes Res (1998) 6(2):97-106. doi:10.1002/j.1550-8528.1998.tb00322.x.
20. Crane PK, Walker R, Hubbard RA, Li G, Nathan DM, Zheng H, et al. Glucose levels and risk of dementia. N Engl J Med (2013) 369(6):540-8. doi:10.1056/NEJMoa1215740.
21. Yarchoan M, Arnold SE. Repurposing diabetes drugs for brain insulin resistance in Alzheimer disease. Diabetes (2014) 63(7):2253-61. doi:10.2337/db14-0287.
22. Mauro C, Marelli-Berg FM. T cell immunity and cardiovascular metabolic disorders: does metabolism fuel inflammation? Front Immunol (2012) 3:173. doi:10.3389/fimmu.2012.00173.
23. Boraldi F, Bini L, Liberatori S, Armini A, Pallini V, Tiozzo R, et al. Proteome analysis of dermal fibroblasts cultured in vitro from human healthy subjects of different ages. Proteomics (2003) 3(6):917-29. doi:10.1002/pmic.200300386.
24. Montiel-Castro AJ, Gonzalez-Cervantes RM, Bravo-Ruiseco G, Pacheco-Lopez G. The microbiota-gut-brain axis: neurobehavioral correlates, health and sociality. Front Integr Neurosci (2013) 7:70. doi:10.3389/fnint.2013.00070.
25. Yaffe K, Kanaya A, Lindquist K, Simonsick EM, Harris T, Shorr RI, et al. The metabolic syndrome, inflammation, and risk of cognitive decline. JAMA (2004) 292(18):2237-42. doi:10.1001/jama.292.18.2237.
26. Arumugam TV, Phillips TM, Cheng A, Morrell CH, Mattson MP, Wan R. Age and energy intake interact to modify cell stress pathways and stroke outcome. Ann Neurol (2010) 67(1):41-52. doi:10.1002/ana.21798.
27. Misiak B, Leszek J, Kiejna A. Metabolic syndrome, mild cognitive impairment and Alzheimer's disease-the emerging role of systemic low-grade inflammation and adiposity. Brain Res Bull (2012) 89(3-4):144-9. doi:10.1016/j.brainresbull.2012.08.003.
28. Procaccini C, Pucino V, De Rosa V, Marone G, Matarese G. Neuro-endocrine networks controlling immune system in health and disease. Front Immunol (2014) 5:143. doi:10.3389/fimmu.2014.00143.
29. Hsu TM, Kanoski SE. Blood-brain barrier disruption: mechanistic links between Western diet consumption and dementia. Front Aging Neurosci (2014) 6:88. doi:10.3389/fnagi.2014.00088.
30. Pardridge WM. Advances in cell biology of blood-brain barrier transport. Semin Cell Biol (1991) 2(6):419-26.
31. Ishida H, Takemori K, Dote K, Ito H. Expression of glucose transporter-1 and aquaporin-4 in the cerebral cortex of stroke-prone spontaneously hypertensive rats in relation to the blood-brain barrier function. Am J Hypertens (2006) 19(1):33-9. doi:10.1016/j.amjhyper.2005.06.023.
32. Erickson MA, Dohi K, Banks WA. Neuroinflammation: a common pathway in CNS diseases as mediated at the blood-brain barrier. Neuroimmunomodulation (2012) 19(2):121-30. doi:10.1159/000330247.
33. Schinkel AH, Wagenaar E, Mol CA, van Deemter L. P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs. J Clin Invest (1996) 97(11):2517-24. doi:10.1172/JCI118699.
34. Banks WA. Characteristics of compounds that cross the blood-brain barrier. BMC Neurol (2009) 9(Suppl 1):S3. doi:10.1186/1471-2377-9-S1-S3.
35. Banks WA, Owen JB, Erickson MA. Insulin in the brain: there and back again. Pharmacol Ther (2012) 136(1):82-93. doi:10.1016/j.pharmthera.2012.07.006.
36. Banks WA, Kastin AJ, Huang W, Jaspan JB, Maness LM. Leptin enters the brain by a saturable system independent of insulin. Peptides (1996) 17(2):305-11. doi:10.1016/0196-9781(96)00025-3.
37. Burguera B, Couce ME, Curran GL, Jensen MD, Lloyd RV, Cleary MP, et al. Obesity is associated with a decreased leptin transport across the blood-brain barrier in rats. Diabetes (2000) 49(7):1219-23. doi:10.2337/diabetes.49.7.1219.
38. De Rosa V, Procaccini C, La Cava A, Chieffi P, Nicoletti GF, Fontana S, et al. Leptin neutralization interferes with pathogenic T cell autoreactivity in autoimmune encephalomyelitis. J Clin Invest (2006) 116(2):447-55. doi:10.1172/JCI26523.
39. Betsholtz C. Physiology: double function at the blood-brain barrier. Nature (2014) 509(7501):432-3. doi:10.1038/nature13339.
40. Carvey PM, Hendey B, Monahan AJ. The blood-brain barrier in neurodegenerative disease: a rhetorical perspective. J Neurochem (2009) 111(2):291-314. doi:10.1111/j.1471-4159.2009.06319.x.
41. Daneman R. The blood-brain barrier in health and disease. Ann Neurol (2012) 72(5):648-72. doi:10.1002/ana.23648.
42. Banks WA, Erickson MA. The blood-brain barrier and immune function and dysfunction. Neurobiol Dis (2010) 37(1):26-32. doi:10.1016/j.nbd.2009.07.031.
43. De Giorgis V, Veggiotti P. GLUT1 deficiency syndrome 2013: current state of the art. Seizure (2013) 22(10):803-11. doi:10.1016/j.seizure.2013.07.003.
44. Parrott MD, Greenwood CE. Dietary influences on cognitive function with aging: from high-fat diets to healthful eating. Ann N Y Acad Sci (2007) 1114:389-97. doi:10.1196/annals.1396.028.
45. Ouyang S, Hsuchou H, Kastin AJ, Wang Y, Yu C, Pan W. Diet-induced obesity suppresses expression of many proteins at the blood-brain barrier. J Cereb Blood Flow Metab (2014) 34(1):43-51. doi:10.1038/jcbfm.2013.166.
46. Shefer G, Marcus Y, Stern N. Is obesity a brain disease? Neurosci Biobehav Rev (2013) 37(10 Pt 2):2489-503. doi:10.1016/j.neubiorev.2013.07.015.
47. Kalaria RN. The blood-brain barrier and cerebrovascular pathology in Alzheimer's disease. Ann N Y Acad Sci (1999) 893:113-25. doi:10.1111/j.1749-6632.1999.tb07821.x.
48. Yates KF, Sweat V, Yau PL, Turchiano MM, Convit A. Impact of metabolic syndrome on cognition and brain: a selected review of the literature. Arterioscler Thromb Vasc Biol (2012) 32(9):2060-7. doi:10.1161/ATVBAHA.112.252759.
49. Jones RG, Thompson CB. Revving the engine: signal transduction fuels T cell activation. Immunity (2007) 27(2):173-8. doi:10.1016/j.immuni.2007.07.008.
50. Frauwirth KA, Riley JL, Harris MH, Parry RV, Rathmell JC, Plas DR, et al. The CD28 signaling pathway regulates glucose metabolism. Immunity (2002) 16(6):769-77. doi:10.1016/S1074-7613(02)00323-0.
51. Wieman HL, Wofford JA, Rathmell JC. Cytokine stimulation promotes glucose uptake via phosphatidylinositol-3 kinase/Akt regulation of Glut1 activity and trafficking. Mol Biol Cell (2007) 18(4):1437-46. doi:10.1091/mbc. E06-07-0593.
52. Peter C, Waldmann H, Cobbold SP. mTOR signalling and metabolic regulation of T cell differentiation. Curr Opin Immunol (2010) 22(5):655-61. doi:10.1016/j.coi.2010.08.010.
53. Powell JD, Delgoffe GM. The mammalian target of rapamycin: linking T cell differentiation, function, and metabolism. Immunity (2010) 33(3):301-11. doi:10.1016/j.immuni.2010.09.002.
54. Maswood N, Young J, Tilmont E, Zhang Z, Gash DM, Gerhardt GA, et al. Caloric restriction increases neurotrophic factor levels and attenuates neurochemical and behavioral deficits in a primate model of Parkinson's disease. Proc Natl Acad Sci U S A (2004) 101(52):18171-6. doi:10.1073/pnas.0405831102.
55. Piccio L, Stark JL, Cross AH. Chronic calorie restriction attenuates experimental autoimmune encephalomyelitis. J Leukoc Biol (2008) 84(4):940-8. doi:10.1189/jlb.0208133.
56. Graff J, Kahn M, Samiei A, Gao J, Ota KT, Rei D, et al. A dietary regimen of caloric restriction or pharmacological activation of SIRT1 to delay the onset of neurodegeneration. J Neurosci (2013) 33(21):8951-60. doi:10.1523/JNEUROSCI.5657-12.2013.
57. Makki K, Froguel P, Wolowczuk I. Adipose tissue in obesity-related inflammation and insulin resistance: cells, cytokines, and chemokines. ISRN Inflamm (2013) 2013:139239. doi:10.1155/2013/139239.
58. Cao H. Adipocytokines in obesity and metabolic disease. J Endocrinol (2014) 220(2):T47-59. doi:10.1530/JOE-13-0339.
59. Lord GM, Matarese G, Howard JK, Baker RJ, Bloom SR, Lechler RI. Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature (1998) 394(6696):897-901. doi:10.1038/29795.
60. De Rosa V, Procaccini C, Cali G, Pirozzi G, Fontana S, Zappacosta S, et al. A key role of leptin in the control of regulatory T cell proliferation. Immunity (2007) 26(2):241-55. doi:10.1016/j.immuni.2007.01.011.
61. Matarese G, Carrieri PB, La Cava A, Perna F, Sanna V, De Rosa V, et al. Leptin increase in multiple sclerosis associates with reduced number of CD4(+)CD25+ regulatory T cells. Proc Natl Acad Sci U S A (2005) 102(14):5150-5. doi:10.1073/pnas.0408995102.